Blaško, P.; Samoš, M.; Bolek, T.; Stančiaková, L.; Škorňová, I.; Péč, M.J.; Jurica, J.; Staško, J.; Mokáň, M.
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth? J. Clin. Med. 2022, 11, 7211.
https://doi.org/10.3390/jcm11237211
AMA Style
Blaško P, Samoš M, Bolek T, Stančiaková L, Škorňová I, Péč MJ, Jurica J, Staško J, Mokáň M.
Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth? Journal of Clinical Medicine. 2022; 11(23):7211.
https://doi.org/10.3390/jcm11237211
Chicago/Turabian Style
Blaško, Peter, Matej Samoš, Tomáš Bolek, Lucia Stančiaková, Ingrid Škorňová, Martin Jozef Péč, Jakub Jurica, Ján Staško, and Marián Mokáň.
2022. "Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?" Journal of Clinical Medicine 11, no. 23: 7211.
https://doi.org/10.3390/jcm11237211
APA Style
Blaško, P., Samoš, M., Bolek, T., Stančiaková, L., Škorňová, I., Péč, M. J., Jurica, J., Staško, J., & Mokáň, M.
(2022). Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth? Journal of Clinical Medicine, 11(23), 7211.
https://doi.org/10.3390/jcm11237211